Biden’s Pick for FDA Gets Bipartisan Support During Hearing
Dec. 14, 2021 — Robert M. Califf, MD, plans to take a close look at federal policies on opioid prescriptions in his expected second turn at the top U.S. regulator of medical products, as well as keep closer tabs on the performance of drugs cleared with accelerated approvals. Califf on Tuesday fielded questions at a … Read more